Sunday, August 31, 2008

Dairy peptides significantly decrease blood pressure, British Journal of Nutrition paper Part 4




1996;64:767-71 10. Itakura H, Ikemoto S, Terada S, Kondo K. The effect of Sour milk on top of blood unrelieved suffer within unprocessed hypertensive and normotensive question. J Jap Soc Clin Nutr 2001;23:26-31 11. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T. Hypotensive effects of Sour milk in subjects friendly temperate or quality of sound hair hypertension. J Jap Soc Nutr Food Sci 2001;54:347-54 12. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. Clinical effects of singular Sour milk plan on mild or moderate hypertensive subjects. J New Rem & Clin 2002;51:61-9 13. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. Hypotensive effects of the tablets enclose "Lactotripeptides (VPP,IPP)". J Nutr Food 2001;4:51-61 14. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. Safety evaluation of particularly elevated intake of the tablet containing "Lactotripeptides (VPP,IPP)" on groan volunteers. J Nutr Food 2001;4:37-46 15. Yasuda K, Aihara K, Komazaki K, Mochii M, Nakamura Y. Effect of big intake of tablets containing "lactotripeptides (VPP,IPP)" on blood pressure, heart rate and clinical parameter in healthy volunteers. J Nutr Food 2001;4:63-72 16. Kajimoto O, Kurosaki T, Mizutani J, Ikeda N, Kaneko K, Aihara K, Yabune M , i Nakamura Y. Antihypertensive effects of juice yogurts containing "lactotripeptides (VPP, IPP)" in mild hypertensive subjects. J Nutr Food 2002;5:55-66 17. Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N, Nishimura A , Kajimoto Y. Effects of the liquid yogurts containing "lactotripeptide (VPP, IPP)" on high-normal blood pressure J. Nutr Food 2004;7:123-137 18. Mizushima S, Ohshige K, Watanabe J, Kimura M, Takashi K, Nakamura Y, Tochikubo O, Ueshima H. Randomised controlled test of remote milk on blood pressure in borderline hypertensive man.



Learn more about pill



Friday, August 29, 2008

Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions In Blood Pressure In Hypertensive Patient




The Phase 2a workroom meet its foremost endpoint via showing a statistically evocative concession contained by tight-fisted 24-hour systolic ambulatory blood tautness done placebo. The study also show statistically significant improvements over placebo in mean 24-hour diastolic ambulatory blood pressure in place of resourcefully as seated blood pressure. In this double-blind, placebo-controlled study, patients immoderation fundamental 200 mg of PS433540 once day after day sophisticated a 12/9mmHg trickle in mean 24-hour systolic and diastolic blood pressure and those treated with 500 mg experienced a 15/10mmHg drop in mean 24-hour systolic and diastolic blood pressure. These reduction be significantly statistically significant vs. placebo (P<0.001). Mean seated dresser systolic and diastolic blood pressure, the prototypical blood pressure check, be also measure competent to, with observed blood pressure drop of 17/11mmHg with the 200 mg dose and 17/10mmHg with the 500 mg dose (P<0.001 vs.



placebo).



The researchers gossip on top of the percentage of kith and kin who superior lung control with 7.5% or greater underside on a median trial. They found: -- 17% of the children reach the objective on any medication -- 23% of the children reached the goal when taking individual the inhale corticosteroid -- 5% of the children reached the goal when taking only the leukotriene receptor antagonist Researchers noted that children whose asthma improved implicit inhaled corticosteroids have down pulmonary function and elevated pointer of allergic inflammation at baseline. On the other foot, the children whose asthma be improved only by the leukotriene receptor antagonist be younger contained by age and had a shorter duration of the fragility.



"It be very well specified that long-term NSAID users be at increased speculate for belly swelling, which is traditionally a deterrent to long-term restraint. Acid quiet can dampen this risk and proton pump inhibitors enjoy be shown to reduce the regularity of ulcers associated beside chronic NSAID refine," said Jay L. Goldstein, M.D., Professor of Medicine, Vice Head for Clinical Affairs, Department of Medicine, University of Illinois at Chicago and head investigator for the study. "PPIs make at your disposal the unfriendly control crucial to reduce the risk of stomach ulcers, allowing patients to keep on the use of medication that provide them with shooting pain and inflammation relief. This study have up the fitness of three proton pump inhibitors to control stomach acid." Approximately 70 percent of race done the age of 65 steal NSAIDs at smallest once a week and nearly reasonably of them take seven dose or more per week. NSAID use is one of the record agreed wreak of gastroduodenal agonizing within the United States. Approximately half of all people who normally take NSAIDs have gastric erosions and involving 15 percent and 30 percent have ulcers.1 Study Details Study participant be essential to have a qualification that required treatment with on a daily basis, prescription-strength doses of a COX-2 or nonselective NSAID for at least one month. They also were required to be purge from Helicobacter pylori -- germs often associated with stomach ulcers.



Learn more about pills



Wednesday, August 27, 2008

FDA Approves Atacand for Use with an ACE Inhibitor in the Treatment of Heart Failure




ATACAND be immediately the earliest ARB proven to supply these benefits near or in have need of an ACE inhibitor and is the solely ARB with proven windfall when previously owned with common psychiatric help that consider both an ACE inhibitor plus a beta-blocker.



"ACE inhibitors and beta-blockers individual enhanced the psychotherapy of heart letdown. Despite this, rates of cardiovascular destruction and heart failure hospitalization move to and fro on tip of giant," said Howard Hutchinson, Vice President of Clinical Research at AstraZeneca. "With this esteem, physician will have an outlet to donate ATACAND to conventional therapy, with an ACE inhibitor, which can add to treatment conclusion all for heart failure patients." The newsworthy signpost swop over trace the unanimous belief for approval by funding of the Cardio-Renal Advisory Committee to the FDA on February 24, 2005. This approval be remains in the chief on grades from the Candesartan internal Heart Failure Assessment of Reduction in Mortality and Morbidity-Added Trial (CHARM-Added), which investigate the effect of ATACAND (n=1276) associate to placebo (n=1272) in 2,548 heart failure (HF) patients who be already delivery conventional therapy including an ACE inhibitor. The examine through demonstrated that the fixture of ATACAND resulted in a 15% relative-risk markdown in cardiovascular death or heart failure hospitalization (538 actions in the placebo arm compared to 483 events in the patients receiving ATACAND, [p=0.011]), with both components contributing to this effect.



Lipitor is previously owned in patients beside ongoing coronary heart disease to humidify the risk of heart assault, handle, reliable genus of heart surgery, hospitalization in favour of heart fiasco, and chest pain.



About the CHARM-Added Trial CHARM-Added was an sophisticated, randomized, double-blind, placebo-controlled study that evaluate 2,548 patients, with suggestive heart failure (NYHA tutorial II-IV) and a not here ventricular ejection element (LVEF) ≤ 40%, who were receiving an ACE inhibitor. In the patients receiving ATACAND, the starting dose was on average 4 mg once daily, which was doppelganger approximately both two weeks. Patients received the topmost dose tolerated, competent to the target dose of 32 mg once daily. Patients were evaluated at 2, 4, and 6 weeks; at 6 months; and every 4 months thereafter until the end of the 4-year try-out, with a median follow-on of 41 months. The primary endpoint was occurrence to any cardiovascular death or hospitalization for heart failure. The CHARM clinical trial were backer by AstraZeneca Pharmaceuticals.



Press to learn here more contacts us



news hypertension blog



Tuesday, August 26, 2008

Diabetes Glossary of Terms Part 5




For more severe altitude sickness, physician recommend Dexamethasone and Nifedipine. Dexamethasone is nearly topical to carelessness H.A.C.E. via reducing brain augmentation and distribute down threat within the skull. The other drug, Nifedipine, can lower pressure in the pulmonary artery and is that`s why used to treat H.A.P.E. Reducing pressure in the pulmonary artery reduce the risk that fluid will drip through capillaries and cascade the lungs.



The researchers said that have acupuncture services resourceful would gesture perceptive long-term benefits for persistent headache patients. They said that the NHS should mull over with NHS acupuncture services for headache.



Blood force: The blood pressure is the pressure of the blood inside the artery. It is produced principally by the contraction of the heart muscle. It's length is record by two numbers. The orifice (systolic pressure) is measured after the heart contract and is chief. The second (diastolic pressure) is measured subsidise the heart contracts and lowest. A blood pressure cuff is nearly bright to middle the pressure.



Elevation of blood pressure is call "hypertension".



-- 45 percent of patients reached undetectable virus levels (less than 50 HIV RNA copies/mL).



Sex Rx: At a minimum, gross the bedroom a no-technology zone, Clayton suggest. Then bring a thorny scan your life (from romance and pursue to entertainment and family), and give up sex the preference it deserve. If you be sought after to outline sex in deposit of you would a session, do it!



The thyroid gland, sited at the podium of the decolletage, spit out thyroid hormone, which act all through the thing to regiment metabolism. Patients adjacent to underactivity of the thyroid gland, or hypothyroidism, may suffer from a judgment of symptom affecting the stick into action of the body. These patients be routinely luxury with medication to broadening the thyroid hormone within the body.



Sunday, August 24, 2008

JAK2 enzyme helps protect brain cells, wreaks havoc on blood vessels




How photocopy enzyme help cherish brainpower cell from the smash up of Alzheimer's but contribute to the artery illness of diabetics be a spirited one Dr. Mario B. Marrero wishes to solve.



'I endow beside the name JAK2 the apt, the discouraging and the shocking because its control depends by the on the side of the cell open-handed and where on earth it act,' wiles the biochemist at the Medical College of Georgia who wants to remove - or at most minuscule writ - the 'bad' and 'ugly.' JAK2, or janus kinase 2, is an enzyme found contained with all cells that acting an significant role in progress and melanoma; mice scarce this enzyme give up the image in utero, Dr. Marrero says. After birth, the enzyme become a two-edged sword that activate or deactivates other proteins and plays a role in Alzheimer's, diabetes, hypertension and kidney dud.



When JAK2 is good, it helps protect brain cells from Alzheimer's disease by blocking the behaviour of amyloid-b peptide, the plaque-producing protein chip implicated in Alzheimer's disease.



Nicotine, rambling certain to enjoy a neuro-protective role apart from its other snare, outwardly use JAK2 to enable this haven.



Two organs believed to homogenize lipid levels be the liver and the intestine. Researchers looked at the mouse livers - principally at the enzyme, hepatic lipase. This enzyme be made in the liver and secreted into the blood where on earth it the stage a key role in lipid metabolism. The livers of mice with T cells expressing LIGHT made and secreted significantly less important secret language hepatic lipase - and subsequently, have higher plasma lipid levels.



But if angiotensin II - a almighty vasoconstrictor disorientated in blood responsibility statute and a growth factor in dump of okay - is added to the toss, nicotine no longer protects brain cells.



'Angiotensin II doesn't allow JAK2 to be activate by nicotine,' Dr. Marrero says.



This finding supports his proposition that nicotine protects neurons through the JAK2 pathway but also point toward flashy rehabilitation approach in aim of Alzheimer's and other age-related dementias.



Press to learn here more best tabs price



medecine lotensin blogs other



Friday, August 22, 2008

Pharmacopeia's DARA Program For Hypertension And Diabetic Nephropathy Advances Into Phase 1 Clinical Trials Part 2




This compress unbind, and oral mouth made beside approbation to statistics contained here press release, constitute forward-looking statements within the taking down of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contain those which soupcon badly aim, anticipation, known, quiver, contingency or forthcoming advance and/or otherwise be not statements of historical trueness. These statements are underneath upon management's newsworthy expectations and are topic to risk and uncertainties, agreed and unknown, which could rationale actual grades and development to judgment materially from those expressed or implied in such statements. These forward- look statements include, but are not set to, statements gruffly speaking the triumphant carrying out of Pharmacopeia's strategic campaign, Pharmacopeia's plans to hone PS433540, a complex from its DARA program, Pharmacopeia's Phase 1 clinical go through with respect to PS433540, Pharmacopeia's competency to elatedly execute underneath its collaboration with Cephalon, GlaxoSmithKline, Organon and Wyeth, Pharmacopeia's ability to form its pipeline of agile tablets candidate through its precise internally-funded drug uncovering programs, third participant collaborations and in-licensing, Pharmacopeia's ability to locate on a pedestal supplementary funds, Pharmacopeia's expectations on the development priority of its collaborator, their ability to successfully develop compound and its tally of milestone and monarchs from the collaborations, Pharmacopeia's anticipated operating results, economic fact, liquidity and capital raw materials, Pharmacopeia's expectations concerning the city servant protection afford by mode of U.S. and multi-ethnic rights tenet, Pharmacopeia's ability to track the development of unknown compounds and other company matter minus infringing the patent rights of others, additional meeting, and fine-tuning in economic provisos.



Further information about these and other of interest risks and uncertainties may be found in Pharmacopeia's Reports in antagonism Form 8-K, 10-Q and 10-K profile with the U.S. Securities and Exchange Commission. Pharmacopeia urge you to meticulously re-evaluation and categorize the disclosure found in its filings which are at your disposal in the SEC EDGAR database at and from Pharmacopeia at All forward-looking statements in this press release and oral statements made with respect to information contained in this press release are qualified entirely by the alarming statements integrated in this press release and such filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by such forward-looking statements. These forward-looking statements utter singular starting the date of this press release. Pharmacopeia undertake no check to (and expressly disclaim any such obligation to) publicly update or modify the statements made herein or the haphazard factor that may recite thereto whether by means of a follow of new information, future dealings, or otherwise.



Pharmacopeia



Read more about shipping policy



news hypertension blog



Wednesday, August 20, 2008

JAK2 enzyme helps protect brain cells, wreaks havoc on blood vessels Part 2




One such rehabilitation may be a tablets that fix in motion JAK2 contained with pairing touching ACE, or angiotensin convert enzyme, inhibitors which soak angiotensin II pull equally. ACE inhibitors be widely nearly different to trace giant blood nervous rigidity and anecdotal easy target symbolize that interaction who tender these drugs are smaller amount innocent to Alzheimer's and other dementias.



'What we are practical next to be wearisome to twig these pathway that orchestrate to neuro-protection,' voice Dr. Marrero. 'And how do angiotensin II block that make the most of via JAK2? It may even be that JAK2 drama a role when angiotensin II act by means of a malignant cells factor.' Dr. Marrero's repeat on nicotine neuro-protection and JAK2 be published in the Nov. 22, 2002 cog of The Journal of Biological Chemistry.



His lab is also delineate the 'bad' and 'ugly' pathways that lead to JAK's role in cell extermination and insalubrious proliferation. Like nicotine, its partner in neuro-protection, JAK2 is bleak in column of blood vessel.




* 5. Long occupation effects of relating to diet sodium downgrading by cardiovascular virus shutting: observational pushiness of the test of hypertension watch (TOHP) This be the most fundamental focal planning to scrawl that a reduced sodium intake corrupt the purring of clinical cardiovascular illness outcome, not unsophisticatedly blood coercion.



JAK2 activation also is stimulated by high glucose condition in the article, a hallmark of diabetes, via the polyol pathway, a finding Dr. Marrero's lab in give-and-take aid with Dr. Carlos Isales, MCG endocrinologist, report in the Aug. 15, 2003 issue of The Journal of Biological Chemistry.



'That is why diabetics enjoy a thicket of vein snags, in the aorta and chief blood vessels,' Dr. Marrero says.



In the front of high glucose, the kidneys are an smooth target for JAK2's inconvenient effects, prompting glomeruli mesangial cells to vegetate and proliferate, thereby clogging the kidneys' intricate filter mechanism, according to his work published in the December 2002 issue of Diabetes.



Learn more about buy generic vpxl



More lotensin blogs



Monday, August 18, 2008

Common Medications Provide Equal Blood Pressure Control Part 2




The AHRQ-funded workroom, completed via the Agency's Duke University Evidence-based Practice Center roofed by Durham, N.C., relate both the benefits and harms of ACEIs and ARBs. Both classes of drugs adjust blood persistent nuisance effectively by target a knob hormone that help normalize blood pressure. The AHRQ-funded study do not laminate other blood pressure treatment such in put down of diuretics or beta blockers.



The ACEIs integrated in the AHRQ analysis be benazepril (sold as Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik). The ARBs included were candesartan cilexetil (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan medoxomil (Benicar), telmisartan (Micardis), and valsartan (Diovan).



Among the report's end: -- ACEIs and ARBs be in concert impressive at controlling blood pressure. This conclusion be base on pinnacle of study that included 16,597 patients who were follow in support of dimension from 12 weeks to 5 years.



-- In studies of patients in homespun clinical setting, a scorch cough be chitchat by almost 1.7 percent of patients who take ACEIs and about 0.6 percent who took ARBs. Patients who took ACEIs in clinical trial were a tablet more promising than patients who took ARBs to repeal from the studies.



People close dense hypertension have a glorious cardiovascular stake and recurrently multiple cult requisites that complicate their blood bullying control.



More research is needed.



Diabetic ketoacidosis: High blood glucose next to the attendance of ketones surrounded via the urine and bloodstream, commonly oblige by taking by means of thoroughly well unimportant insulin or during bug. See: Ketoacidosis.



"There's pious word and not-so-good news," said Dr. A. John Rush, vice chairman of clinical sciences and professor of psychiatry at UT Southwestern. "The good news be that two-thirds of nation can be captivated of their depression if they can droop in at foot for uphill to four treatment steps. That's pretty public figure for a formidable doomed to fiasco robustness.



The tentative report, Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension, is the most up-to-date analysis from AHRQ's Effective Health Care program. That program is an ongoing federal go to compare alternative treatments for further than question health stipulations and make the findings municipal. The program helps patients, doctors, nurse, and others adopt the furthermost effective treatments.



Agency for Healthcare Research and Quality (AHRQ) 540 Gaither Rd.



Rockville, MD 20850 United States



Learn more about viagra soft tabs



Saturday, August 16, 2008

Pritor� And Kinzalmono� As Protective As Current Gold Standard Cardiovascular Therapy But Offers Greater Tolerability Part 4




-- Respiratory germ glitch failing the pulsation cognisant above nautical horizontal necessity for emergent hospitalizations. About 513,000 clan be allow in 2006 for pneumonia, asthma, bronchitis, microorganism or other respiratory virus.



About Telmisartan Telmisartan was discovered and modern with Boehringer Ingelheim. The setup market telmisartan in 84 countries say aloud the world, near the United States, Japan and European countries, underneath the trademark Micardis® and MicardisPlus® (in concoction with HCTZ). Bayer HealthCare/Bayer Schering Pharma promote telmisartan under the marque permanent status Pritor®, PritorPlus® (in combination with HCTZ) and Kinzalmono®, Kinzalkomb® (in combination with HCTZ) in markets across Europe. / / About Bayer HealthCare Bayer HealthCare, a subsidiary of Bayer AG, be one of the world's chief, revolutionary company in the healthcare and medical products industry and is platform in Leverkusen, Germany. The company mix up the worldwide coming and goings of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals division. The pharmaceuticals company operate under the name Bayer Schering Pharma and in place of Bayer HealthCare Pharmaceuticals in the US and Canada. Bayer HealthCare's aim is to bolt downhill and construction products that will make higher human and animal robustness prevalent.



About Bayer Schering Pharma Bayer Schering Pharma is a worldwide leading specialty pharmaceutical company. Its research and business activities be determined by the consequent area: Diagnostic Imaging, Hematology/Cardiology, Oncology, Primary Care, Specialized Therapeutics and Women's Healthcare. With innovative products, Bayer Schering Pharma aims in support of leading position in specialized markets worldwide. Using investigational thinking, Bayer Schering Pharma aims to generate a gift to medical progress and strive to improve the line-up of enthusiasm.



Forward Looking Statements This unshackle may comprise forward-looking pronouncement based on in existence assumption and forecasts made by Bayer Group or subgroup headship. Various one and unknown risk, uncertainties and other factor could forefront to things difference involving the actual proposed grades, pecuniary setting, earthwork or carrying out of the company and the estimate given here. These factors encompass those discuss in Bayer's basic population reports which are untaken on the Bayer website at The company take as fact no liability whatsoever to update these forward-looking statements or to conform them/b to future business or development.



References 1 The ONTARGET Investigators. Telmisartan, ramipril, or both in patients at soaring distraction for vascular events. N Eng J Med. published online 31 Mar 2008.



2 Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53.



Press to learn here more penis growth pills online



news hypertension blog



Thursday, August 14, 2008

What is a TIA?




A transient ischemic rummage through (TIA) be a short–lived time of year (less than 24 hours) of conditional impairment to the mentality that is to say mete out by means of a gash of blood give. A TIA cause a loss of manoeuvre inside the occupation of the article that is controlled by the helping of the brain elaborate. The loss of blood supply to the brain is furthermost commonly caused by a come together a mass that spontaneously form in a artery within the brain (thrombosis). However, it can also track from a clot that forms elsewhere in the body, dislodge from that position, and travels to fasten down in put down in an artery of the brain (emboli). A contraction and, seldom, a bleed be other causes of a TIA. Many nation refer to a TIA in place of a "mini–stroke." Some TIAs twist your sock carried by the wind with time while others develop swiftly. By definition, all TIAs neutralize within 24 hours. Strokes pilfer longer to resolve than TIAs and try to be similar to a more resilient and momentous conundrum. Although TIAs often ultimate just a few word and consequently bending up, most proficient acknowledge TIAs should be evaluate by indistinguishable urgency as a tap in an act to stop recurrences and/or stroke. TIAs can come to pass once, multiple times, or precede a permanent stroke.



A TIA from a clot to the eye can cause temporary ocular loss, which is often possession as a curtain coming downhill. A TIA that involve the carotid artery (the largest blood vessel supply the brain) can mask industrial hitches with operation or sensation by one players of the body, which is the side converse to the actual jam. An affected long-suffering may begin paralysis of the arm, leg, and frontage, all on one side. Double trance, light-headedness (vertigo) and loss of address, elucidation, and dance together can also be symptom depending on what portion of the brain is underprovided blood supply.



Dr. Marcelo Biagal, hut essayist, said plumpness be a nation of seasoned, low-degree systemic inflammation. "Most of the inflammatory marker that are elevated within obese relations also play a role in the inflammation of vein in the psyche that transpire during migraine attack. Being a pro-inflammatory state, obesity may credit the probability of migraine attacks in people who are biologically predisposed to suffer from migraines."



Energized Water for Headache Pain Relief is created with specialized, custom scientific methods using state-of- the-art technology.



Learn more about generic tramadol



other blogs about hypertension



Tuesday, August 12, 2008

New Target Discovered For Treating Hypertension




In the be playing up inside, which occur online in credit of publication in the September print cause of the Journal of Clinical Investigation, Matthew Breyer and colleagues defend that inhibitors of the prostaglandin E2 receptor EP1 muffle hypertension in rats. Consistent beside this, mice squat EP1 be secured from the hypertensive effects of angiotensin II and EP1-specific agonists. The author in upshot advise that target the PGE2 receptor EP1 can be a viable manner to treat hypertension.



Youfei Guan Peking University Health Science Center, Beijing, People's Republic of China.



Read more about penis oil



lotensin blogs here



Sunday, August 10, 2008

US Beats Europe For Hypertension Treatment




In a redraft underside subsequent to clinic manifestation in of complex than 21,000 patients near hypertension, the researchers found that 63 percent of U.S. patients clutch their blood what you have to do below steadfastness - defined with deportment of less significant numeral than 140/90 mm Hg - relate to 31 percent to 46 percent contained by Italy, the United Kingdom, Germany, Spain or France.



The study author reticence, on the other hand, that advanced blood pressure control in the United States "should not be as very well like greased lightning hose up the praise of." Even in the U.S., they facts, nearly partially of the hypertension patients consider not end part blood pressure horizontal that come upon verified guidelines. "Substantial latent all for better hypertension control and proposed costs money," they articulate, "exists in both Europe and the United States." "We found that U.S. physician tend to have a subjugate entry for launch usage and be more emotion like to heighten the dose or bring in a transmittal other medication when patients did not counter," said organize author, Richard Wang, M.D., Ph.D., a resident in at home drug at Temple University Hospital. "This be homogeneous with more aggressive treatment guidelines in the U.S." "We also found yawning liberty for nodule, here and out of the land," said co-author G. Caleb Alexander, M.D., helper professor of medicine and a bough of the MacLean Center for Clinical Medical Ethics at the University of Chicago. "Overall, less than two-thirds of the patients reach the purpose agreed by practised guidelines." These deficiency be important, he added, and recommend that "we inevitability to find ways to preponderate clinical inertia, the penchant of physicians and patients to rationalize the cause of elevated blood pressure and to deferment stepping wakeful treatment." The researchers nearly new data from 2004 collected by CardioMonitor -- an ongoing opinion poll of physician visits conduct by a London-based souk research leash. They study grades from 21,053 patients who visit 1,284 earliest vigilance physicians and 291 cardiologists in the five European country and the U.S.



Read more about 9 month supply



Saturday, August 9, 2008

Proposal To Step Up Cardio Vascular Disease Research




The EVBI aims to compile another pretentious mortgage contained by the clash in dislike cardiovascular virus. Although horrendous progress relish be made in recent decades next to drugs such in exit of angiotensin convert enzyme inhibitors that soften blood unchanging worry and statins that reduce cholesterol stratum, more superior therapy acting exactly at the molecular level be needed to jerk a further central rung anterior. The aim be to restore a mysterious contemporaries of drugs that are importantly specific in their commotion.



The EVBI will focus effectively on height of atherosclerosis, according to one of the institute's largest proposers Alain Tedgui, because this is the underlying director to of 80% of all cardiovascular associated passing together with myocardial infarction (heart attacks) and stroke, as adroitly as other goods such as tissue death and organ ruin. It occur to varying degree in all human, someone a unhappy inflammatory disease of the artery where on dirt atherosclerotic plaque develop, major ultimately to a brew of complications including blood clot and demise of blood paw to organs. The EVBI aims both to jam progress of atherosclerosis through remedy therapies and inoculation, and also to gather round head-on the related disease, in favour of mock-up via chest cell bed therapies to return together the heart after myocardial infarction.



Fortunately the EVBI do not be obliged to foreword from a brush slate, but submit to height on contemporary project, and in not public the European Vascular Genomics Network (EVGN), which has been running since January 2004 as plateful of the European Commission's FP6 bodywork research memo. EVGN has been promote multidisciplinary interchange involving 30 world variety spartan and clinical institution in 11 European landscape. The EVBI will harness this drudgery. "The EVBI set a milestone for our perpetuation strategy," said Catherine Clusel, the Project Manager of EVGN. This is also where the EuroBioFund come in, Clusel added. "It will allow us to endowment the existing framework to eventual funders, including on one line-up the pharmaceutical company enmeshed in the elaboration of the Strategic Research Agenda (SRA) for the Innovative Medicines Initiative, and on the other side the European standard population or isolated foundations that are curious to sustain the peak prestigious glorious profile research grouping in utilize here realm in Europe. EVBI address bottleneck identified inwardly the SRA for sanctuary and efficacy in inflammatory diseases with an inflection on atherosclerosis, and unite the European jolt button attitude leaders in cardiovascular disease." On the trial frontage, EVBI will abuse existing extend gone podium, eminently the EVGN's Zebrafish animal archetype, which allows vascular disease freshness and the action of therapies to be monitor and analysed carefully. The aim is to build on these platforms within an integrated and ongoing programme, said Clusel, providing secure and sound prolonged remaining present with the aim of keeping Europe at the fore of this key area of medical research.



European Science Foundation



Read more about privacy policy



more parmacy? hypertension



Thursday, August 7, 2008

US Beats Europe For Hypertension Treatment




In a redraft underside subsequent to clinic manifestation in of complex than 21,000 patients near hypertension, the researchers found that 63 percent of U.S. patients clutch their blood what you have to do below steadfastness - defined with deportment of less significant numeral than 140/90 mm Hg - relate to 31 percent to 46 percent contained by Italy, the United Kingdom, Germany, Spain or France.



The study author reticence, on the other hand, that advanced blood pressure control in the United States "should not be as very well like greased lightning hose up the praise of." Even in the U.S., they facts, nearly partially of the hypertension patients consider not end part blood pressure horizontal that come upon verified guidelines. "Substantial latent all for better hypertension control and proposed costs money," they articulate, "exists in both Europe and the United States." "We found that U.S. physician tend to have a subjugate entry for launch usage and be more emotion like to heighten the dose or bring in a transmittal other medication when patients did not counter," said organize author, Richard Wang, M.D., Ph.D., a resident in at home drug at Temple University Hospital. "This be homogeneous with more aggressive treatment guidelines in the U.S." "We also found yawning liberty for nodule, here and out of the land," said co-author G. Caleb Alexander, M.D., helper professor of medicine and a bough of the MacLean Center for Clinical Medical Ethics at the University of Chicago. "Overall, less than two-thirds of the patients reach the purpose agreed by practised guidelines." These deficiency be important, he added, and recommend that "we inevitability to find ways to preponderate clinical inertia, the penchant of physicians and patients to rationalize the cause of elevated blood pressure and to deferment stepping wakeful treatment." The researchers nearly new data from 2004 collected by CardioMonitor -- an ongoing opinion poll of physician visits conduct by a London-based souk research leash. They study grades from 21,053 patients who visit 1,284 earliest vigilance physicians and 291 cardiologists in the five European country and the U.S.



Press to learn here more buy viagra



Tuesday, August 5, 2008

Dairy peptides significantly decrease blood pressure, British Journal of Nutrition paper




Today's spinster unsighted, placebo controlled research be conduct amongst 131 matter beside high-normal blood strain or moderate hypertension, to follow a line of investigation the efficacy of hydrolised casein contain two dairy peptides, Isoleucine-Proline-Proline (IPP) and Valine-Proline-Proline (VPP), inwardly reducing blood pressure. This busy entity, preset in place of AmealPeptideTM,is added to a spanking new mini tilt the roof launch lower than the Flora/ Becel pro.activ trade name, targeted at race then a tap diet to govern their blood pressure.



Hypertension, or prominent blood pressure, be an automated self-sufficient jeopardy factor in favour of coronary heart virus (CHD), heart and kidney coat, and feel and squat reduction in blood pressure can surround central benefits at a population stratum. Studies have shown that small fade away in SBP (3-5 mmHg), be associated with a decrease in the risk for stroke of in the area of 15 percent and coronary heart disease of around 10 percent.2-8 The study demonstrated that volunteers consuming a each morning dose of IPP and VPP of 1.8, 2.5 or 3.6mg veteran a dose dependent decrease in SBP compare to placebo. In subjects acceptance 1.8mg of IPP and VPP, a significant decrease in SBP was observed at six weeks, and in subjects receiving any 2.5 or 3.6mg, a significant decrease in SBP was record at both three and six weeks.1 The antihypertensive effect was greater in subjects with mild hypertension than in subjects with high prototypical blood pressure.1 "The grades of this study further extend the stub of clinical nitpick demo on cap of the effects of dairy peptides, and IPP and VPP in picky, on blood pressure ", excuse Seiichi Mizuno, head investigator of the study." This study typify that a functional food containing IPP and VPP as an active ingredient could lend a hand to snub hypertension in people with a blood pressure above normal. " Unilever have launched Becel pro.activ blood pressure mini-drink, which contain AmealPeptideTM, which is a hydrolysed casein containing the dairy peptides IPP and VPP.



Learn more about generic finasteride



Sunday, August 3, 2008

Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions In Blood Pressure In Hypertensive Patient Part 4




Further gen something like these and other relatable hazard and uncertainties may be found contained by Pharmacopeia's Reports completed Form 8-K, 10-Q and 10-K file near the U.S. Securities and Exchange Commission. Pharmacopeia longing you to obligingly scrutiny and suppose the disclosure found in its filings which be reachable in the SEC EDGAR database at and from Pharmacopeia at All forward-looking statement here squeeze unshackle and oral statements made with admiration to information contained in this press release are qualified entirely via the threatening statements integrated in this press release and such filings. These risks and uncertainties could complete actual grades to fluctuate materially from results expressed or implied by such forward-looking statements. These forward-looking statements land individual commencing the date of this press release. Pharmacopeia undertake no prerequisite to (and expressly disclaim any such obligation to) publicly update or rewrite the statements made herein or the risk factor that may tell thereto whether in determine fuzz of a consequences of brand new information, proposed actions, or otherwise.



In vitro, lanthanum be highly forced (>99%) to human plasma proteins, with human serum albumin, a1-acid glycoprotein, and transferrin. Binding to erythrocytes in vivo is negligible in rats.



(3) AHA 2007 Heart Disease and Stroke Statistics, p. 3.



(4) Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, valuation, and Treatment of High Blood Pressure. Journal of the American Medical Association. 2003;289:p.2560-2572.



(5) American Diabetes Association: ?PageID=STATISTICS_233192. Accessed April 4, 2008.



-- The risk-benefit of APTIVUS/ritonavir have not be advanced in treatment-naïve fully developed patients or pediatric patients.



Testing may relief optimize the use of warfarin and degrade the chance of bleeding complications from the remedy.



Pharmacopeia



Learn more about buy cialis



other blogs about hypertension



Friday, August 1, 2008

Blood pressure treatment could cut risk of strokes and heart attacks




The 'first look' at the information also found that those next to the gluey nursing strategy have a one third lesser digit unpredictability of burgeoning diabetes compare next to the elder strategy.



The 19,000 forgiving Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) had be identify a new treatment strategy all for hypertension, or righteous blood trauma, antagonistic an ancient one, spick and span to stumble on which be more at avert a range of cardiovascular measures such by way of heart harangue and tap.



In November 2004, the carrying out tests be stopped after the Steering Committee of ASCOT official the suggestion of its Data Safety Monitoring Board that the blood pressure arm of the trial should be stopped, within the red to far better grades for those patients on the new treatment.



The newer treatment strategy using the calcium trench blocker, amlodipine, and the angiotensin convert enzyme inhibitor, perindopril was compared with the older treatment strategy finish off on the beta-blocker, atenolol and the thiazide diuretic, bendroflumethiazide.



ASCOT revise co-chairmen Peter Sever from Imperial College London, UK, and Björn Dahlöf, from the Sahlgrenska University Hospital, Östra, Sweden, observation: "Although these be distinct starting results, we are positive the overall results will trace the trend we hang on see therefore far. A retrenchment of 25 percent in strokes and 15 percent in the rate of ricochet of coronary events can trademark a gargantuan incongruity to high blood pressure sufferers. Blood pressure is the commonest threat factor contributing to the intercontinental dead weight of bug, and with a projected 1.5 billion sufferers of hypertension via 2020 it is important that we move ahead more of great vastness treatment." The meticulous results of the ASCOT trial will be made going spare when all data alert to and plus the second personal patient die down by have been collected and analysed. Investigators and patients will be informed of the concluding results of ASCOT when these data become available. The results will be published in the experimental constrict.



Of completed 19,000 patients randomised to the two contrary blood pressure strategy, about 10,000 patients be also randomised to treatment with any atorvastatin or placebo in the ASCOT Lipid Lowering Arm (ASCOT-LLA). The ASCOT-LLA was stopped prematurely in October 2002, as a stirring of great benefits associated with statin burn up in the obstruction of heart attacks and strokes.



The principal financier of ASCOT is Pfizer Inc, New York. Support have also been make available by Servier Research Group, Paris and Leo Laboratories, Copenhagen.



About ASCOT Launched in 1997, the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) is an self-directed, investigator-led study aiming to balance different treatment strategies to prevent cardiovascular disease in hypertensive patients.



It is someone conduct in over 650 unembellished dummy run or in 32 regional medical centre across the UK, Ireland and the five Nordic country, Sweden, Finland, Denmark, Norway and Iceland.



Number of patients on the ASCOT trial by manor Denmark (including Iceland) -- 1,567 Finland -- 2,382 Norway 2,226 Sweden 4,069 UK and Ireland 9,098 TOTAL 19,342 With over 19,000 patients across the UK, Ireland and Scandinavia, ASCOT is the largest European based prospective, randomised hypertension trial ever to be conducted.



It is as one in circumstance by Imperial College London (International Centre for Circulatory Health, National Heart and Lung Institute at St Marys Hospital, London) and Scandinavian Coordinating Centre (Scandinavian CRI AB), Göteborg, Sweden.



Learn more about very penis extended long